Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Common Equity (2016 - 2025)

Historic Common Equity for Qiagen (QGEN) over the last 17 years, with Q3 2025 value amounting to $3.6 billion.

  • Qiagen's Common Equity rose 338.3% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 338.3%. This contributed to the annual value of $3.6 billion for FY2024, which is 631.41% down from last year.
  • Latest data reveals that Qiagen reported Common Equity of $3.6 billion as of Q3 2025, which was up 338.3% from $3.5 billion recorded in Q2 2025.
  • Qiagen's 5-year Common Equity high stood at $3.8 billion for Q4 2023, and its period low was $2.8 billion during Q1 2021.
  • In the last 5 years, Qiagen's Common Equity had a median value of $3.5 billion in 2022 and averaged $3.4 billion.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 3028.19% in 2021, then tumbled by 631.41% in 2024.
  • Quarter analysis of 5 years shows Qiagen's Common Equity stood at $3.1 billion in 2021, then increased by 11.95% to $3.5 billion in 2022, then grew by 9.84% to $3.8 billion in 2023, then decreased by 6.31% to $3.6 billion in 2024, then rose by 2.3% to $3.6 billion in 2025.
  • Its Common Equity stands at $3.6 billion for Q3 2025, versus $3.5 billion for Q2 2025 and $3.4 billion for Q1 2025.